{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T05:24:11Z","timestamp":1782969851685,"version":"3.54.5"},"reference-count":49,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2005,8,1]],"date-time":"2005-08-01T00:00:00Z","timestamp":1122854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2005,8]]},"DOI":"10.1016\/j.pbb.2005.06.007","type":"journal-article","created":{"date-parts":[[2005,7,7]],"date-time":"2005-07-07T14:03:38Z","timestamp":1120745018000},"page":"805-813","source":"Crossref","is-referenced-by-count":196,"title":["Neuroprotection by crocetin in a hemi-parkinsonian rat model"],"prefix":"10.1016","volume":"81","author":[{"given":"Abdullah Shafique","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mubeen Ahmad","family":"Ansari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzamil","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofiyan","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seema","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Nasrul","family":"Hoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fakhrul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2005.06.007_bib1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0006-8993(97)01505-9","article-title":"Crocin antagonizes ethanol inhibition of NMDA receptor-mediated responses in rat hippocampal neurons","volume":"787","author":"Abe","year":"1998","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2005.06.007_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/newbio245150a0","article-title":"Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat","volume":"245","author":"Agid","year":"1973","journal-title":"Nat New Biol"},{"key":"10.1016\/j.pbb.2005.06.007_bib3","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1471-4159.2005.03000.x","article-title":"Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences","volume":"93","author":"Ahmad","year":"2005","journal-title":"J Neurochem"},{"issue":"Pt 1","key":"10.1016\/j.pbb.2005.06.007_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1042\/bj3240025","article-title":"Glutathione transferases catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes","volume":"324","author":"Baez","year":"1997","journal-title":"Biochem J"},{"key":"10.1016\/j.pbb.2005.06.007_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/biof.5520090222","article-title":"Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases","volume":"9","author":"Beal","year":"1999","journal-title":"Biofactors"},{"key":"10.1016\/j.pbb.2005.06.007_bib6","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0006-2952(02)01174-7","article-title":"Glutathione, iron and Parkinson's disease","volume":"64","author":"Bharath","year":"2002","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.pbb.2005.06.007_bib7","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0301-0082(01)00003-X","article-title":"Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease","volume":"65","author":"Blum","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2005.06.007_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1471-4159.1980.tb07102.x","article-title":"Regional distribution of glutathione peroxidase in the adult rat brain","volume":"35","author":"Brannan","year":"1980","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2005.06.007_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/0006-8993(89)91530-8","article-title":"Vitamin E attenuates the toxic effects of intrastriatal injection of 6-hydroxydopamine (6-OHDA) in rats: behavioral and biochemical evidence","author":"Cadet","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2005.06.007_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/S0076-6879(85)13062-4","article-title":"Glutathione reductase","volume":"113","author":"Carlberg","year":"1985","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pbb.2005.06.007_bib11","series-title":"CRC handbook of methods for oxygen radical research","author":"Claiborne","year":"1985"},{"key":"10.1016\/j.pbb.2005.06.007_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/0028-3908(89)90130-5","article-title":"Methamphetamine-induced neuronal damage: a possible role for free radicals","volume":"28","author":"De Vito","year":"1989","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2005.06.007_bib13","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1046\/j.1432-1327.2000.01651.x","article-title":"Glutathione metabolism and oxidative stress in neurodegeneration","volume":"267","author":"Dringen","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.pbb.2005.06.007_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/MN:29:1:15","article-title":"Pathogenesis of Parkinson's disease: prospects of neuroprotective and restorative therapies","volume":"29","author":"Fernandez-Espejo","year":"2004","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.pbb.2005.06.007_bib15","first-page":"709","article-title":"Iron as a vulnerability factor in nigrostriatal degeneration in aging and Parkinson's disease","volume":"46","author":"Floor","year":"2000","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"10.1016\/j.pbb.2005.06.007_bib16","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1002\/ana.410320706","article-title":"Free radical damage to protein and DNA: mechanisms involved and relevant observations on brain undergoing oxidative stress","volume":"32","author":"Floyd","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pbb.2005.06.007_bib17","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/0006-8993(94)91968-2","article-title":"Behavioral asymmetries and recovery in rats with different degrees of unilateral striatal dopamine depletion","volume":"664","author":"Fornaguera","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2005.06.007_bib18","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/BF01932451","article-title":"The use of crocetin in experimental atherosclerosis","volume":"31","author":"Gainer","year":"1975","journal-title":"Experientia"},{"key":"10.1016\/j.pbb.2005.06.007_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1196\/annals.1296.066","article-title":"Oxidative stress to dopaminergic neurons as models of Parkinson's disease","volume":"1018","author":"Gille","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pbb.2005.06.007_bib20","doi-asserted-by":"crossref","first-page":"7130","DOI":"10.1016\/S0021-9258(19)42083-8","article-title":"Glutathione-S-transferases. The first enzymatic step in mercapturic acid formation","volume":"249","author":"Habig","year":"1974","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2005.06.007_bib21","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1471-4159.1992.tb10990.x","article-title":"Reactive oxygen species and the central nervous system","volume":"59","author":"Halliwell","year":"1992","journal-title":"J Neurochem"},{"key":"10.1016\/j.pbb.2005.06.007_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/0003-9861(86)90305-X","article-title":"Oxygen free radicals and iron in relation to biology and medicine: some problems and concepts","volume":"246","author":"Halliwell","year":"1986","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pbb.2005.06.007_bib23","first-page":"95","article-title":"The decarboxylation of DOPA in the parkinsonian brain: in vivo studies on an animal model","author":"Hefti","year":"1980","journal-title":"J Neural Transm, Suppl"},{"key":"10.1016\/j.pbb.2005.06.007_bib24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0166-4328(02)00087-6","article-title":"Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat","volume":"139","author":"Henderson","year":"2003","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2005.06.007_bib25","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1021\/bi00695a010","article-title":"The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme","volume":"14","author":"Hodgson","year":"1975","journal-title":"Biochemistry"},{"key":"10.1016\/j.pbb.2005.06.007_bib26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0733-8619(18)30217-2","article-title":"What process causes nigral cell death in Parkinson's disease?","volume":"10","author":"Jenner","year":"1992","journal-title":"Neurol Clin"},{"key":"10.1016\/j.pbb.2005.06.007_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000136485","article-title":"Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite","volume":"11","author":"Jollow","year":"1974","journal-title":"Pharmacology"},{"key":"10.1016\/j.pbb.2005.06.007_bib28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pbb.2005.06.007_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1353-8020(02)00018-4","article-title":"Glutathione depletion and oxidative stress","volume":"8","author":"Mytilineou","year":"2002","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.pbb.2005.06.007_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/cbr.1993.8.339","article-title":"Protective effects of crocetin on the bladder toxicity induced by cyclophosphamide","volume":"8","author":"Nair","year":"1993","journal-title":"Cancer Biother"},{"key":"10.1016\/j.pbb.2005.06.007_bib31","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1212\/WNL.38.11.1667","article-title":"(S)-emopamil, a novel calcium channel blocker and serotonin S2 antagonist, markedly reduces infarct size following middle cerebral artery occlusion in the rat","volume":"38","author":"Nakayama","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2005.06.007_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","article-title":"Etiology and pathogenesis of Parkinson's disease","volume":"22","author":"Olanow","year":"1999","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pbb.2005.06.007_bib33","series-title":"The rat brain stereotaxic coordinates","author":"Paxinos","year":"1982"},{"key":"10.1016\/j.pbb.2005.06.007_bib34","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1523\/JNEUROSCI.14-05-02687.1994","article-title":"Time course of recovery of extracellular dopamine following partial damage to the nigrostriatal dopamine system","volume":"14","author":"Robinson","year":"1994","journal-title":"J Neurosci"},{"key":"10.1016\/j.pbb.2005.06.007_bib35","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0091-3057(02)01030-4","article-title":"Protective effect of Nardostachys jatamansi in rat cerebral ischemia","volume":"74","author":"Salim","year":"2003","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2005.06.007_bib36","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0005-2728(98)00164-9","article-title":"Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia","volume":"1410","author":"Schapira","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pbb.2005.06.007_bib37","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00441-004-0938-y","article-title":"Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP","volume":"318","author":"Schober","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.pbb.2005.06.007_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/jcbfm.1986.126","article-title":"Carotenoid compound crocetin improves cerebral oxygenation in hemorrhaged rats","volume":"6","author":"Seyde","year":"1986","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.pbb.2005.06.007_bib39","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s007020050171","article-title":"Parkinson's disease: a major hypokinetic basal ganglia disorder","volume":"106","author":"Sian","year":"1999","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pbb.2005.06.007_bib40","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1097\/00003246-200006000-00047","article-title":"Intravenous crocetinate prolongs survival in a rat model of lethal hypoxemia","volume":"28","author":"Singer","year":"2000","journal-title":"Crit Care Med"},{"key":"10.1016\/j.pbb.2005.06.007_bib41","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/diabetes.49.6.1006","article-title":"Effects of dl-alpha-lipoic acid on peripheral nerve conduction, blood flow, energy metabolism, and oxidative stress in experimental diabetic neuropathy","volume":"49","author":"Stevens","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.pbb.2005.06.007_bib42","first-page":"60","article-title":"Free radical toxicity and antioxidants in Parkinson's disease","volume":"51","author":"Sudha","year":"2003","journal-title":"Neurol India"},{"key":"10.1016\/j.pbb.2005.06.007_bib43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0304-3835(95)03964-X","article-title":"Crocetin protects against oxidative damage in rat primary hepatocytes","volume":"97","author":"Tseng","year":"1995","journal-title":"Cancer Lett"},{"key":"10.1016\/j.pbb.2005.06.007_bib44","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pneurobio.2004.05.002","article-title":"Genes, proteins, and neurotoxins involved in Parkinson's disease","volume":"73","author":"von Bohlen und Halbach","year":"2004","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.pbb.2005.06.007_bib45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1093\/carcin\/12.3.459","article-title":"Effects of crocetin on the hepatotoxicity and hepatic DNA binding of aflatoxin B1 in rats","volume":"12","author":"Wang","year":"1991","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pbb.2005.06.007_bib46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/(SICI)1098-2744(199612)17:4<235::AID-MC7>3.0.CO;2-C","article-title":"Inhibition of protein kinase C and proto-oncogene expression by crocetin in NIH\/3T3 cells","volume":"17","author":"Wang","year":"1996","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.pbb.2005.06.007_bib47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0003-2697(90)90668-Y","article-title":"Automated assays for superoxide dismutase, catalase, glutathione peroxidase, and glutathione reductase activity","volume":"184","author":"Wheeler","year":"1990","journal-title":"Anal Biochem"},{"key":"10.1016\/j.pbb.2005.06.007_bib48","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1006\/abbi.1994.1444","article-title":"The reaction of superoxide with reduced glutathione","volume":"314","author":"Winterbourn","year":"1994","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pbb.2005.06.007_bib49","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1471-4159.2003.01531.x","article-title":"Dose-dependent protective effect of selenium in rat model of Parkinson's disease: neurobehavioral and neurochemical evidences","volume":"84","author":"Zafar","year":"2003","journal-title":"J Neurochem"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705002054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305705002054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T04:19:30Z","timestamp":1626149970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305705002054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,8]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2005,8]]}},"alternative-id":["S0091305705002054"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2005.06.007","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2005,8]]}}}